BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32213630)

  • 1. Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells.
    Peired AJ; Antonelli G; Angelotti ML; Allinovi M; Guzzi F; Sisti A; Semeraro R; Conte C; Mazzinghi B; Nardi S; Melica ME; De Chiara L; Lazzeri E; Lasagni L; Lottini T; Landini S; Giglio S; Mari A; Di Maida F; Antonelli A; Porpiglia F; Schiavina R; Ficarra V; Facchiano D; Gacci M; Serni S; Carini M; Netto GJ; Roperto RM; Magi A; Christiansen CF; Rotondi M; Liapis H; Anders HJ; Minervini A; Raspollini MR; Romagnani P
    Sci Transl Med; 2020 Mar; 12(536):. PubMed ID: 32213630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells.
    Saleeb RM; Farag M; Ding Q; Downes M; Bjarnason G; Brimo F; Plant P; Rotondo F; Lichner Z; Finelli A; Yousef GM
    Am J Pathol; 2019 Oct; 189(10):2046-2060. PubMed ID: 31381885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human de novo papillary renal-cell carcinomas in a kidney graft: evidence of recipient origin with adenoma-carcinoma sequence.
    Verine J; Varna M; Ratajczak P; El-Bouchtaoui M; Leboeuf C; Plassa LF; Soliman H; Sandid W; Abboud I; Bousquet G; Verneuil L; Peraldi MN; Mongiat-Artus P; Janin A
    Am J Transplant; 2013 Apr; 13(4):984-992. PubMed ID: 23425311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.
    Skenderi F; Ulamec M; Vanecek T; Martinek P; Alaghehbandan R; Foix MP; Babankova I; Montiel DP; Alvarado-Cabrero I; Svajdler M; Dubinský P; Cempirkova D; Pavlovsky M; Vranic S; Daum O; Ondic O; Pivovarcikova K; Michalova K; Hora M; Rotterova P; Stehlikova A; Dusek M; Michal M; Hes O
    Ann Diagn Pathol; 2017 Apr; 27():48-56. PubMed ID: 28325361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
    Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
    Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma.
    Wang Q; Zhang Y; Zhang B; Fu Y; Zhao X; Zhang J; Zuo K; Xing Y; Jiang S; Qin Z; Li E; Guo H; Liu Z; Yang J
    Nat Commun; 2022 Jan; 13(1):31. PubMed ID: 35013217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
    Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
    Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity of DNA repair gene, hOGG1, in renal cell carcinoma but not in renal papillary adenoma.
    Gokden N; Li L; Zhang H; Schafer RF; Schichman S; Scott MA; Smoller BR; Fan CY
    Pathol Int; 2008 Jun; 58(6):339-43. PubMed ID: 18477212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
    Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
    Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.
    Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
    Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
    Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.
    Liu K; Ren Y; Pang L; Qi Y; Jia W; Tao L; Hu Z; Zhao J; Zhang H; Li L; Yue H; Han J; Liang W; Hu J; Zou H; Yuan X; Li F
    Int J Clin Exp Pathol; 2015; 8(7):8311-35. PubMed ID: 26339402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
    Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
    Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary Renal Cell Carcinoma (PRCC): An Update.
    Akhtar M; Al-Bozom IA; Al Hussain T
    Adv Anat Pathol; 2019 Mar; 26(2):124-132. PubMed ID: 30507616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
    Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
    Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
    Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
    Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
    Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
    PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
    Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.